The new bid surpasses an offer SK Capital and Carlyle Group made last month for the gene therapy developer, which Bluebird’s board still supports.

US gene therapy company bluebird bio (Nasdaq: BLUE) has confirmed receipt of an unsolicited non-binding written proposal from ...

Explore bluebird bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BLUE. BlueBird Shares Are Up Today: What's Going On? Bluebird Bio Inc. (NASDAQ ...

bluebird has opted to launch it at a cost of $2.8 million, which compares to the $1.7 million price tag attached to the therapy when it was first made available in Europe, and is also well above ...

As the snow fell on the night of Thursday, April 3rd, indie pop duo Evening Elephants hit the Bluebird Theater on their ...

Donald Campbell CBE died aged 45 on Coniston Water, Cumbria, in January 1967 when his Bluebird K7 hydroplane flipped and crashed at 328mph. In 2001 his body and Bluebird were both recovered and ...

for $102 million net – just weeks after investors bid $30 million for Bluebird itself – seemed to place a final blow on what was once a promising gene therapy company. The space in general has ...

Nicola Redfern, bluebird bio’s UK general manager ... a real potential alternative as a one-off resolution to this life-limiting condition.” ...